Topics
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Contact Us
|
About IDSA
|
Membership
|
Member Networking
|
Find a Member
Log In
|
Register
Topics of Interest
Antimicrobial Resistance
Bioterrorism
Emerging Infections
Global ID
Hepatitis C
HIV
Immunization
Influenza
Lyme Disease
Manage Your Practice
Physician Payments
Billing & Coding
Quality Improvement
Value of ID Specialists
Health Information Technology
Medicare & Your Practice
Forms & Documents
Access and Reimbursement
Practice Management Listserve
HR & Staffing
Drug Shortages
Guidelines/Patient Care
IDSA Practice Guidelines
Guideline Methodology and Other Resources
For Patients & Public
Careers & Training
ID/HIV Career Center
Student & Resident Opportunities
Fellows-in-Training Center
Program Director Resources
Continuing Medical Education
Maintenance of Certification
Online Courses & Exams
Research & Funding Opportunities
International HIV Training Opportunities
Policy & Advocacy
Access & Reimbursement
Antimicrobial Resistance
Infection Prevention & Control
HIV/AIDS & Global TB
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
News & Publications
Clinical Infectious Diseases
Journal of Infectious Diseases
IDSA News
HIVMA eNews
Science Speaks Blog
For Media
News Releases from IDSA
News from the Journals
Meetings
IDWeek 2013
IDWeek 2012
About Annual Meeting CME
Past Meetings
ID-Related Meetings Calendar
Annual Meeting Abstract Archives
View Menu
Guidelines
A-Z Index
Topics of Interest
Antimicrobial Resistance
Bioterrorism
Emerging Infections
Global ID
Hepatitis C
HIV
Immunization
Influenza
Lyme Disease
Manage Your Practice
Physician Payments
Billing & Coding
Quality Improvement
Value of ID Specialists
Health Information Technology
Medicare & Your Practice
Forms & Documents
Access and Reimbursement
Practice Management Listserve
HR & Staffing
Drug Shortages
Guidelines/Patient Care
IDSA Practice Guidelines
Guideline Methodology and Other Resources
For Patients & Public
Careers & Training
ID/HIV Career Center
Student & Resident Opportunities
Fellows-in-Training Center
Program Director Resources
Continuing Medical Education
Maintenance of Certification
Online Courses & Exams
Research & Funding Opportunities
International HIV Training Opportunities
Policy & Advocacy
Access & Reimbursement
Antimicrobial Resistance
Infection Prevention & Control
HIV/AIDS & Global TB
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
News & Publications
Clinical Infectious Diseases
Journal of Infectious Diseases
IDSA News
HIVMA eNews
Science Speaks Blog
For Media
News Releases from IDSA
News from the Journals
Meetings
IDWeek 2013
IDWeek 2012
About Annual Meeting CME
Past Meetings
ID-Related Meetings Calendar
Annual Meeting Abstract Archives
Home
>
Policy & Advocacy
>
Antimicrobial Resistance
Print
ShareThis
Text Size
Access & Reimbursement
Antimicrobial Resistance
Antibiotic Development: 10x'20
Strengthening U.S. Efforts
Antimicrobial Stewardship
Antibiotics in Agriculture
Antimicrobial Resistance by State
Infection Prevention & Control
HIV/AIDS & Global TB
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
View All Letters on US Resistance Efforts
Search More Letters
09/19/2012
IDSA Letter to HHS on Antimicrobial Resistance and Immunization Policies (PDF)
IDSA urges Secretary Sebelius to act on Senate recommendations regarding antimicrobial resistance, antibiotic research and development, and immunization policies.
06/14/2011
IDSA Comments on Draft Antimicrobial Resistance Action Plan (PDF)
IDSA opined on the draft revised federal Action Plan to Combat Antimicrobial Resistance published by the federal Interagency Task Force in March 2011. IDSA highlighted the need for greater leadership, coordination, non-government expert input, accountable measures, and resources.
06/08/2011
IDSA Letter to NIAID on Clinical Trials Network and Repository
IDSA letter supporting the new NIAID clinical trials network primarily focused on bacterial antibiotic resistance. IDSA also proposed the establishment of an ID clinical specimen repository, which could be housed at NIAID and linked to clinical trials conducted through the network and other sites.
04/07/2011
IDSA Letter to President Obama raising concerns about the Federal Approach to Resistance (PDF)
IDSA asks the White House to act to strengthen leadership and coordination of federal efforts.
08/19/2010
IDSA Suggests Changes to NIAID Clinical Trials Infrastructure
In a letter to NIAID Director Fauci, IDSA provided its input on the future structure and objectives of NIAID's clinical trials infrastructure.
06/17/2010
IDSA Urges Action by Trans-Atlantic Task Force on Antimicrobial Resistance (PDF)
IDSA applauds the first meeting of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR), but urges Task Force members to take swift action on the issue of antimicrobial resistance through collaboration and adoption of global efforts to combat resistance, such as the
10x'20 initiative
.
10/19/2009
IDSA Urges NIAID Clinical Trial Networks Expansion into New Areas (PDF)
NIAID officials are examining the possibility of expanding the Institute’s clinical trials networks to cover tuberculosis, hepatitis C, influenza research. IDSA supports this proposal and has requested that resistant bacterial infections also be considered.
06/19/2007
IDSA Letter to NIAID and CDC Requesting a Strengthened Federal Response to Antimicrobial Resistance (PDF)
In a letter to Dr. Anthony Fauci, NIAID, and Julie Gerberding, CDC, IDSA called for the creation of an NIH/CDC joint antimicrobial resistance strategic research plan as well as the joint establishment of an Antimicrobial Resistance Clinical Research and Public Health Network as proposed in the Strategies to Address Antimicrobial Resistance Act.
Subscribe for Updates
Average 0 out of 5
|
HIVMA
|
Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America
Full Site
Mobile Site